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SUMMARY
This is a review of existing data on the burden of shigellosis in Thailand to determine trends,
vulnerable groups, predominant species and serotypes, and antimicrobial resistance patterns.
Diarrhoea and dysentery morbidity and mortality data from 1991 to 1999 was collected from the
routine surveillance system and demographic data from the government census. International and
local literature published between 1988 and 2000 was systematically reviewed. Based on the
routine surveillance system, the annual incidence of bacillary dysentery decreased from 1.3 to
0.2/10 000 persons per year. The remaining burden is highest in children<5 years of age at
2.7/10 000 persons per year. In comparison, a prospective study utilizing active surveillance found
an incidence in children<5 years of age that was more than 100-fold higher at 640/10 000
persons per year. Despite the decrease in morbidity and mortality based on routinely collected
data, shigellosis remains an important problem in children<5 years of age in Thailand.
INTRODUCTION
Diarrhoea is a major public health problem but the
combined inﬂuence of multiple factors has reduced its
impact in several countries around the world [1].
These factors include home-based interventions such
as encouraging breastfeeding, childhood nutrition,
and oral rehydration; health centre-based strategies
on diarrhoea case management, measles immuniz-
ation, and provision of vitamin A; and national
improvements in socio-economic status, water supply,
and sanitation. In particular, oral rehydration
therapy is credited with the reduction in childhood
diarrhoea mortality from 4.6 million in 1980 to 1.5
million in 2000 [2].
As the morbidity and mortality from diarrhoeal
diseases decrease, more attention has turned to
bacillary dysentery (shigellosis), since its treatment is
complicated by the emergence of antimicrobial
resistance [3]. Antimicrobial agents previously used as
ﬁrst-line therapy such as ampicillin and cotrimoxazole
have become ineﬀective against Shigella spp. The
organism is rapidly becoming resistant to nalidixic
acid, leaving few treatment options.
As Thailand makes its transition from a developing
to an industrialized country, the shift from rural to
urban living, increased life expectancy and other
demographic changes are transforming the health
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problems of its population. A critical analysis of the
burden of speciﬁc diseases could be useful in
developing targeted control measures towards
continued improvement of health conditions. This is a
review of the burden of shigellosis in Thailand, based
on existing data sources from the past decade to
determine trends in morbidity and mortality, vulner-
able groups, predominant species and serotypes, and
antimicrobial resistance patterns.
MATERIALS AND METHODS
The ﬂow of information in the routine national health
surveillance system of Thailand is shown in Figure 1.
Standard forms for notiﬁable diseases are completed
by the health service units and submitted at the dis-
trict, provincial, or central level. The reported cases
are diagnosed following ICD-10 deﬁnitions [4]. The
data is collated and analysed in the Epidemiology
Division of the Ministry of Public Health and pub-
lished annually [5]. We abstracted the number of cases
and deaths from diarrhoea and dysentery from the
1991–1999 annual reports. Demographic data from
the government census [6] was used to calculate inci-
dence per 10 000 persons per year and age group. The
data were entered and graphs created in Microsoft
Oﬃce Excel 2003 (Microsoft Corporation, Redmond,
WA USA). Standard deviation for incidence by age
group was calculated using SAS (SAS Institute Inc,
Cary, NC, USA). x2 test for trend was calculated to
assess the decrease in case-fatality rate over time using
Epi-Info 6.0 [Centers for Disease Control and
Prevention (CDC), Atlanta, GA, USA].
International and local literature published
between 1988 and 2000 was systematically reviewed
using various combinations of the key words: diar-
rhoea, dysentery, bacillary dysentery, shigellosis, and
Thailand. This was done to compare and supplement
the data from the national health surveillance system.
Emphasis was placed on epidemiological studies and
review articles, which were included if they met pre-
determined criteria. Cohort studies were included if
they described at least 1 year’s prospective surveil-
lance, with at least weekly visits to detect diarrhoea,
appropriate clinical case deﬁnitions or culture conﬁr-
mation using standard microbiological methods, and
a clear population denominator. Outbreak investi-
gations were excluded. Case-control studies and case
series were included if they described at least 25 cases
and utilized standard methods for serotyping and
antimicrobial susceptibility testing. The selected
articles were reviewed and data extracted on to a
standardized form. The data was entered and graphs
created in Excel.
RESULTS
Government data
In the year 2000, the total population of Thailand was
approximately 62 million. Approximately 5 million
(8%) were <5 years of age (Fig. 2). The current
population represents an increase from 56 million in
1991, or a growth of approximately 620 000 per year
(1.1%).
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Fig. 1. Health Information System of Thailand.
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The reported annual incidence of acute diarrhoea
and dysentery (bacillary, amoebic, and of unspeciﬁed
aetiology) from 1991 to 1999 based on the govern-
ment’s routine national surveillance system is shown
in Figure 3. The incidence of reported acute diarrhoea
remained stable over time, ranging from 140 to 190/
10 000 persons. The incidence of amoebic dysentery
was similarly stable, ranging from 0.2 to 0.4/10 000
person. In contrast, the reported incidence of bacil-
lary dysentery decreased more than sixfold from 1.3
to 0.2/10 000 persons.
The incidence of bacillary dysentery fell in all age
groups. However, the burden remains highest in
children <5 years of age. Over the last decade, the
average annual incidence of bacillary dysentery in
those aged <5 years was 2.7/10 000 persons per year
compared to 0.4/10000 persons per year among those
aged o5 years (P value <0.01). Although children
<5 years of age make up only 8% of the total popu-
lation, they accounted for 43% of bacillary dysentery
cases. The incidence of bacillary dysentery is lowest in
middle life and increases among those over 45 years of
age, producing a U-like curve (Fig. 4). The reported
case-fatality rate of bacillary dysentery from 1991 to
1999 ranged from 0% to 0.16% (Table 1). Most
recently, the reported case-fatality rate has been nil.
Published data
The incidence of diarrhoea and shigellosis in children
f5 years of age in a low-income community in
Bangkok was measured by a household-based pro-
spective study from 1988 to 1989 [7]. Compared to the
government data, the incidence of shigellosis detected
by active surveillance in children<5 years of age was
more than 100-fold higher at 640/10 000 per year
(Table 2). Shigella was isolated starting at 6 months of
age and 19% of diarrhoeal episodes in children were
associated with shigella infections.
At the Children’s Hospital in Bangkok, Shigella
spp. was isolated from 94 (23%) of 410 children with
diarrhoea [8]. When only mucoid or bloody stools
were considered, isolation rates were higher at 47/91
(52%) and 88/200 (44%) respectively.
Shigella spp. isolation in community-based [9] and
hospital-based [10–12] studies is shown in Table 3. In
general, the most common shigella serogroup isolated
was S. ﬂexneri (79%), followed by S. sonnei (15%).
Only 4% were S. dysenteriae and 2% S. boydii. S.
sonnei was relatively more frequent in community-
compared to hospital-based studies.
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Fig. 3. Annual incidence of reported acute diarrhoea compared with dysentery, Thailand, 1991–1999 [5].
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Fig. 4. Average reported annual incidence (with standard
deviations) of bacillary dysentery by age group, Thailand,
1991–1999 [5].
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As shown in Figure 5, a study from 1985 to 1992 at
a rural hospital in Nakhon Nayok, Thailand showed
resistance rates of 72–90% to ampicillin and an in-
crease in resistance to cotrimoxazole from 29% to
89% over the years [13]. In this study, no resistance
was noted against nalidixic acid or cefotaxime. A
study in Bangkok in 1988 showed the pattern of re-
sistance of the four Shigella spp. to the commonly
used antibiotics (Table 4). Overall, 87% of the
shigella isolates were resistant to ampicillin, 84% to
cotrimoxazole, and 0.1% to nalidixic acid [8].
DISCUSSION
Despite the decrease in morbidity and mortality from
shigellosis suggested by the routine national health
surveillance system, shigellosis remains an important
problem in children<5 years of age in Thailand. The
government data is useful for the detection of trends
but comparison with a household-based prospective
study using active surveillance suggests that the actual
incidence is likely to be several-fold higher. Since the
government data relies on passive surveillance, noti-
ﬁcation rates are aﬀected by whether patients seek
medical care, whether the correct diagnosis is made,
and whether notiﬁcation is forwarded to the relevant
authority. On the other hand, the prospective study
was conducted at a speciﬁc site where the disease is
believed to be a problem and the results may not be
representative of the whole country.
The incidence rates from the household-based pro-
spective study fall between those seen in industrialized
and developing countries [3], and are most compar-
able to those in a newly industrialized country like
Israel, which is not surprising considering Thailand’s
status as a transition country. On the other hand, the
Table 1. Reported case-fatality rate of bacillary dysentery by age group (%), Thailand, 1991 to 1999 [5]
1991 1992 1993 1994 1995 1996 1997 1998 1999
Cases 7368 5213 4314 3768 3160 2048 1687 1988 1316
Deaths 7 4 7 3 2 3 1 0 0
Case-fatality rate* (%) 0.10 0.08 0.16 0.08 0.06 0.15 0.06 0.00 0.00
* x2 test for trend=1.7 (P=0.2).
Table 2. Incidence of reported diarrhoea and
shigellosis from 1988 to 1989, by age group, in a
low-income urban community in Bangkok from a
household-based prospective study [7]
Age group
Incidence per 10 000 children
% diarrhoea
cases
conﬁrmed
as shigellosisDiarrhoea Shigellosis
0–5 months 20 000 0 0
6–11 months 24 000 864 4
1–2 years 12 000 612 5
2–5 years 4000 444 11
Table 3. Comparison of Shigella spp. isolation between
a community-based study in 1991 [9] and hospital-based
studies from 1988 to 1994 [10–12]
Shigella spp.
Community-based
study
Hospital-based
study
No. % No. %
S. sonnei 25 28 249 14
S. boydii 1 1 35 2
S. dysenteriae
2–10
4 4 71 4
S. ﬂexneri 60 67 1427 80
Total 90 100 1782 100
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Fig. 5. Percentage of antimicrobial resistance of shigella
isolates, Nakhon Nayok, Thailand, 1985–1992 [13].
472 H. Lee and others
mortality estimate (0–0.16%) is lower than the 0.7%
rate that was estimated in a previous paper [3].
S. ﬂexneri is typically the predominant species in
developing countries [3]. Probably as a reﬂection of
the transition of Thailand’s economy towards in-
creasing industrialization, we found S. sonnei to be an
emerging species in this review. This ﬁnding is
supported by a recently completed prospective popu-
lation-based survey in Keangkoi, a rural area in
Thailand. The surveillance identiﬁed S. sonnei as the
predominant species in the study site (Chompook, P.,
unpublished observations).
The antimicrobial susceptibility patterns conﬁrm
increasing resistance of shigella to the commonly used
antibiotics [3, 14]. Our data indicate that neither
ampicillin nor cotrimoxazole can currently be used
for empiric treatment. Although nalidixic acid (given
orally four times a day for 5 days), second-generation
quinolones such as ciproﬂoxacin (given orally twice a
day for 3 days) and third-generation cephalosporins
(given parenterally) are still eﬀective in Thailand, it is
probably only a matter of years before the organisms
develop resistance to these drugs as well.
Our ﬁndings underscore the burden of shigellosis in
young children. The increased incidence of shigellosis
in older populations is an interesting observation,
which to our knowledge, has not been previously re-
ported. In fact, there are few published data address-
ing the burden of shigellosis in adults [3]. Our ﬁndings
suggest that this issue should be carefully assessed
through prospective research.
A safe and eﬀective vaccine against shigellosis
would be a potentially important public health tool.
For Thailand, the vaccine would need to be eﬀective
against S. ﬂexneri and S. sonnei and should protect
children starting at 6 months of age. Considering that
most shigella vaccines under development are
designed to provide immunity that is serotype-
speciﬁc, additional data are needed to determine the
distribution of S. ﬂexneri serotypes.
Analysis such as this is an example of the possible
uses of existing data from routine national reporting
systems and published literature. Retrospective
analyses are useful to assess the success of disease
control programmes, identify priorities, allocate
resources, and detect unusual patterns that warrant
further attention, such as the apparent vulnerability
of the elderly to shigellosis. The accuracy of such data
varies depending on the level of development in the
country, the resources available, the infrastructure
and technical capacity present. Each of these factors
inﬂuences the quality of routine reporting and
research. Notiﬁcation rates also depend on the type of
disease, whether patients seek medical care, whether
the correct diagnosis is made, and whether notiﬁ-
cation is forwarded to the relevant authority. Due to
these many variables, it is often not possible to
provide conclusive results. Despite its limitations, we
believe that the data presented here suggests the
importance of shigellosis in young children and
the need for a safe and eﬀective vaccine.
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Table 4. Drug resistance pattern of Shigella spp., Bangkok, Thailand, 1988 [8]
Shigella spp.
Percentage resistant
Ampicillin Chloramphenicol
Nalidixic
acid
Trimethoprim–
sulphamethoxazole Tetracycline
S. boydii
(n=33)
18 42 0 27 85
S. dysenteriae
(n=46)
22 74 0 70 91
S. ﬂexneri
(n=1280)
98 99 0 88 98
S. sonnei
(n=186)
42 45 1 72 96
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